PATENT CLAIM ANALYSIS

Application Number: 15779021
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "750000"]

Abstract:
An angiogenesis inhibitor effective in inhibiting angiogenesis which causes a disease is obtained by, for example, sterilely filtrating, disinfecting, and concentrating a product which is obtained as follows. That is, rice bran is extracted with hot water, the insoluble matter is filtrated, and the starch is decomposed by processing the filtrate with glucoamylase, thereby obtaining a water-soluble polysaccharide extract. Ammonium sulfate is added to a culture filtrate prepared by culturing  Lentinula edodes  of basidiomycetes, thereby obtaining an enzyme complex from the precipitate. This enzyme complex is added to the water-soluble polysaccharide extract, and the mixture is caused to react at a pH of 4.5 for 30 to 60 min and further react at a pH of 6.0 for 30 to 60 min, thereby biologically modifying the water-soluble polysaccharide extract and obtaining the product.

Claim (Index 2):
The angiogenesis inhibitor according to  claim 1 , wherein the product is a polysaccharide complex.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.94737
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15608656', '15589162', '15074493', '13987544', '12628592']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7121268628008748
- 35 USC 102 Novelty (BERT): 0.4905521094374689
- Combined Prediction Score: 0.6899693874645342
- Mean Citation Score: 150.76672399999995
- Max Citation Score: 161.82072
- Similarity Product: 103.57980354706764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test